Drugwonks Hits the Highbeam Top10

  • by: |
  • 01/14/2012

HighBeam Research chooses top 10 blogs for medical research

When looking for understanding and information, most people turn first to the Internet, and in return, those with information are sharing it via online sites and blogs. This may be the most true within the medical community. Blogs and online libraries have grown to be valuable resources for students, professors, working professionals and the general public who have not traditionally had such easy access. As an organization involved with medical research and providing medical resources, HighBeam Research would like to acknowledge our favorite medical blogs.

These top 10 blogs for medical research were handpicked by the HighBeam Research staff as our favorites and included based on their level of insightful and original content as well as the authority and trust that the authors enjoy in the Medical space. Here are our picks:

  • Science Based Medicine: Dedicated to evaluating medical treatments and products of interest to the public in a scientific light
  • Corante: In the Pipeline: Weblog about developments in pharmacology and chemistry
  • Life in the Fast Lane: Dedicated to providing online emergency medicine and critical care insights
  • Clinical Correlations: The NYU Langone Internal Medicine Blog – A Daily Dose of Medicine
  • Science Roll: A doctor’s journey in genetics PhD and medicine through Web 2.0
  • Dr. Shock: Focusing on psychology and the treatment of depression
  • Cases Blog: Health news updated daily by an Assistant Professor at University of Chicago
  • DrugWonks: The web log of the Center for Medicine in the Public Interest (CMPI), a forum offering rigorous and compelling research on the most critical issues affecting current drug policy
  • Academic Life in Emergency Medicine: Collaborating, meeting, and sharing with inspiring people in the academic world of Emergency Medicine
  • BMA Blog: Views from BMA Cymru Wales on health, politics and just about anything
CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog